» Articles » PMID: 33166439

Gestational Diabetes and Overt Diabetes First Diagnosed in Pregnancy: Characteristics, Therapeutic Approach and Perinatal Outcomes in a Public Healthcare Referral Center in Brazil

Overview
Specialty Endocrinology
Date 2020 Nov 9
PMID 33166439
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe the clinical characteristics, management, and fetal outcomes of patients diagnosed with gestational diabetes mellitus (GDM) or overt diabetes (OD) during pregnancy who followed up at a public healthcare referral center in Brazil.

Methods: A retrospective cohort study based on the medical records of women diagnosed with dysglycemia during pregnancy between January 2015 and July 2017 was conducted.

Results: Out of 224 pregnant women evaluated, 70% were overweight/obese. GDM was observed in 78.6% of pregnant women, while 21.4% presented with OD. Approximately 59% of patients could be diagnosed with GDM or OD by fasting plasma glucose (FPG) alterations alone. Exclusive diet therapy was used in 50.9% of patients. The need for insulin therapy was higher in OD patients (60.4%) than in GDM patients (38.1%) (p = 0.006). Women who needed insulin (n = 96) had a mean initial dose of 0.33 IU/kg (±0.27) and a final value of 0.39 IU/kg (±0.34). The cesarean rate was 74.3%. The fetal outcomes evaluated were macrosomia (2.15%), large for gestational age (LGA) fetus (15.83%), intensive care unit (ICU) need (4.32%), Apgar score ≤7 (6.47%), hypoglycemia (14.39%) and jaundice (16.55%).

Conclusion: Patients with GDM and OD presented with several similar clinical features. Approximately half of the patients presented with adequate glycemic control only with diet management. Patients with OD presented a higher need for insulin therapy. Although overweight and obesity were frequent within both groups, they could possibly explain many of our findings.

Citing Articles

Incidence of overt diabetes in pregnancy among women with 50-g glucose challenge test ≥ 200 mg/dL.

Boriboonhirunsarn D, Robkhonburi A, Gusonkhum D Diabetol Int. 2024; 15(3):406-413.

PMID: 39101181 PMC: 11291839. DOI: 10.1007/s13340-024-00694-w.


A Brazilian cohort of pregnant women with overt diabetes: analyses of risk factors using a machine learning technique.

Reichelt A, de Campos M, Hirakata V, Genro V, Oppermann M Arch Endocrinol Metab. 2023; 67(5):e000628.

PMID: 37249459 PMC: 10665057. DOI: 10.20945/2359-3997000000628.


Evolution of Gestational Diabetes Mellitus across Continents in 21st Century.

Dluski D, Ruszala M, Rudzinski G, Pozarowska K, Brzuszkiewicz K, Leszczynska-Gorzelak B Int J Environ Res Public Health. 2022; 19(23).

PMID: 36497880 PMC: 9738915. DOI: 10.3390/ijerph192315804.


Overt diabetes imposes a comparable burden on outcomes as pregestational diabetes: a cohort study.

Oppermann M, Campos M, Hirakata V, Reichelt A Diabetol Metab Syndr. 2022; 14(1):177.

PMID: 36419098 PMC: 9685976. DOI: 10.1186/s13098-022-00939-1.


Effect of Overt Diabetes and Gestational Diabetes Mellitus on Pregnancy Outcomes and Progression.

Nabi T, Rafiq N, Arifa Q, Mishra S J Obstet Gynaecol India. 2022; 72(Suppl 1):235-242.

PMID: 35928066 PMC: 9343514. DOI: 10.1007/s13224-022-01649-4.


References
1.
Sugiyama T, Saito M, Nishigori H, Nagase S, Yaegashi N, Sagawa N . Comparison of pregnancy outcomes between women with gestational diabetes and overt diabetes first diagnosed in pregnancy: a retrospective multi-institutional study in Japan. Diabetes Res Clin Pract. 2014; 103(1):20-5. DOI: 10.1016/j.diabres.2013.10.020. View

2.
Jiang Y, Chen X, Ding T, Wang X, Zhu Z, Su S . Comparative efficacy and safety of OADs in management of GDM: network meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2015; 100(5):2071-80. DOI: 10.1210/jc.2014-4403. View

3.
Koning S, Scheuneman K, Lutgers H, Korteweg F, van den Berg G, Sollie K . Risk stratification for healthcare planning in women with gestational diabetes mellitus. Neth J Med. 2016; 74(6):262-9. View

4.
Balsells M, Garcia-Patterson A, Sola I, Roque M, Gich I, Corcoy R . Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ. 2015; 350:h102. PMC: 4301599. DOI: 10.1136/bmj.h102. View

5.
Ovesen P, Jensen D, Damm P, Rasmussen S, Kesmodel U . Maternal and neonatal outcomes in pregnancies complicated by gestational diabetes. a nation-wide study. J Matern Fetal Neonatal Med. 2014; 28(14):1720-4. DOI: 10.3109/14767058.2014.966677. View